Evidence map›Paper›PMID 15044704›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

The spatial orientation of Helicobacter pylori in the gastric mucus.

Sören Schreiber, Manuela Konradt, Claudia Groll, Peter Scheid, Guido Hanauer, Hans-Otto Werling, Christine Josenhans, Sebastian Suerbaum

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07293910 (Safety and Efficacy of Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection), which is not on this map. Cited by 163 papers.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07293910 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Efficacy of Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

TypeinterventionalSponsorTanta UniversityRan2026 to 2026Enrolled66ConditionsHELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection, Helicobacter Pylori Infected PatientsArmsVonoparazan, Vitamin D, Probiotic, Amoxicillin, Clarithromycin 500 mg
3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 330 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Managing dangerous liaisons: lessons fromJournal of bacteriology · 2026
    Review
  5. Review
  6. Article
  7. Gut microbes · 2025
    Article
  8. FlgY, PflA, and PflB form a spoke-ring network in the high-torque flagellar motor ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Enhancement of bacterial rheotaxis in non-Newtonian fluids.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Galectin-2 AgglutinatesInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Pathogens (Basel, Switzerland) · 2024
    Review
  18. The gut microbiota and its biogeography.Nature reviews. Microbiology · 2024
    Review
  19. Article
  20. Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sören SchreiberInstitut für Physiologie, Ruhr-Universität Bochum, D-44780 Bochum, Germany. soeren.shreiber@ruhr-uni-bochum.de
Manuela Konradt
Claudia Groll
Peter Scheid
Guido Hanauer
Hans-Otto Werling
Christine Josenhans
Sebastian Suerbaum
Medizinische Hochschule Hannover · DERuhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The highly motile human pathogen Helicobacter pylori lives deep in the gastric mucus layer. To identify which chemical gradient guides the bacteria within the mucus layer, combinations of luminal perfusion, dialysis, and ventilation were used to modify or invert transmucus gradients in anaesthetized Helicobacter-infected mice and Mongolian gerbils. Neither changes in lumen or arterial pH nor inversion of bicarbonate/CO2 or urea/ammonium gradients disturbed Helicobacter orientation. However, elimination of the mucus pH gradient by simultaneous reduction of arterial pH and bicarbonate concentration perturbed orientation, causing the bacteria to spread over the entire mucus layer. H. pylori thus uses the gastric mucus pH gradient for chemotactic orientation.

Indexed as

AnimalsBicarbonatesCarbon DioxideFemaleGastric MucosaHelicobacter pyloriHydrogen-Ion ConcentrationMiceQuaternary Ammonium CompoundsUreaBicarbonatesCarbon DioxideQuaternary Ammonium CompoundsUrea

Identifiers

PMID15044704
PMCPMC387367
OpenAlexW2047043794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.